Pesquisa

Ultramicronized N-palmitoylethanolamine Contributes to Morphine Efficacy Against Neuropathic Pain: Implication of Mast Cells and Glia

Micheli L., Lucarini E., Nobili S., Bartolucci G., Pallecchi M., Toti A., Ferrara V., Ciampi C., Ghelardini C., Di Cesare Mannelli L.

(Eng)

Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward

Song X., Fan C., Atta-ur-Rahman , Choudhary M., Wang X.

(Eng)

Recombinant Antibody Fragments for Neurological Disorders: An Update

Manoutcharian K., Gevorkian G.

(Eng)

Reduced Serum Brain-Derived Neurotrophic Factor in Infants Affected by Severe Bronchiolitis

Nenna R., Petrella C., Bonci E., Papoff P., Jorgi M., Petrarca L., Conti M., Barbato C., Pietrangeli A., Fiore M., Midulla F., Group B.

(Eng)

Brain Disorder Detection and Diagnosis using Machine Learning and Deep Learning A Bibliometric Analysis

Deshpande G., Chaki J.

(Eng)

Volume 22, Nº 6 (2024)

Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)

Singh S., Chib S., Akhtar M., Kumar B., Chawla P., Bhatia R.

(Eng)

Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders

Wiefels M., Furar E., Eshraghi R., Mittal J., Memis I., Moosa M., Mittal R., Eshraghi A.

(Eng)

Gut Microbiome in Alzheimers Disease: from Mice to Humans

Liang C., Pereira R., Zhang Y., Rojas O.

(Eng)

Volume 22, Nº 11 (2024)

Boltzmanns Theorem Revisited: Inaccurate Time-to-Action Clocks in Affective Disorders

Ferber S., Weller A., Soreq H.

(Eng)

Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimers Disease from 2002 to 2022

Cai H., Du R., Yang K., Li W., Wang Z.

(Eng)

Astrocytes and Memory: Implications for the Treatment of Memory-related Disorders

Wang J., Cheng P., Qu Y., Zhu G.

(Eng)

Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022

Murray A., Biscussi B., Cavallaro V., Donozo M., Rodriguez S.

(Eng)

Volume 22, Nº 6 (2024)

A Comprehensive Review on the Importance of MiRNA-206 in the Animal Model and Human Diseases

Qi W., Guan W.

(Eng)

Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinsons Disease

Wamelen D., Leta V., Chaudhuri K., Jenner P.

(Eng)

Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?

Savoie F., Arpin D., Vaillancourt D.

(Eng)

Volume 22, Nº 2 (2024)

Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience

Zanghì A., Ferraro D., Callari G., Valentino P., Granella F., Patti F., Lus G., Bonavita S., Moretti M., Avolio C., DAmico E.

(Eng)

The Common Denominators of Parkinsons Disease Pathogenesis and Methamphetamine Abuse

Vincent B., Shukla M.

(Eng)

Paraquat and Parkinsons Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis

Chung See W., Naidu R., Tang K.

(Eng)

Volume 22, Nº 12 (2024)

Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential

Paola R., Siracusa R., Fusco R., Ontario M., Cammilleri G., Pantano L., Scuto M., Tomasello M., Spanò S., Salinaro A., Abdelhameed A., Ferrantelli V., Arcidiacono A., Fritsch T., Lupo G., Signorile A., Maiolino L., Cuzzocrea S., Calabrese V.

(Eng)

In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimers Disease

Sun Y., Zhao J., Lu Y., Ngo F., Shuai B., Zhang Z., Feng Y., Rong J.

(Eng)

Volume 22, Nº 12 (2024)

Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimers Disease: Recent Advances and Therapeutic Implications

Rahman M., Rahman M., Rhim H., Kim B.

(Eng)